CPHI - China Pharma Holdings, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 511.18M
Enterprise Value 318.02M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.01
Price/Book (mrq)0.39
Enterprise Value/Revenue 31.63
Enterprise Value/EBITDA 6-19.37

Trading Information

Stock Price History

Beta (3Y Monthly) 1.44
52-Week Change 312.13%
S&P500 52-Week Change 3-0.33%
52 Week High 30.8400
52 Week Low 30.1900
50-Day Moving Average 30.2850
200-Day Moving Average 30.3073

Share Statistics

Avg Vol (3 month) 3267.32k
Avg Vol (10 day) 389.58k
Shares Outstanding 543.58M
Float 21.94M
% Held by Insiders 149.66%
% Held by Institutions 12.04%
Shares Short (Jul 31, 2019) 4115.87k
Short Ratio (Jul 31, 2019) 40.48
Short % of Float (Jul 31, 2019) 40.48%
Short % of Shares Outstanding (Jul 31, 2019) 40.27%
Shares Short (prior month Jun 28, 2019) 45.26k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 221804/1000
Last Split Date 3Aug 15, 2003

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -96.96%
Operating Margin (ttm)-36.69%

Management Effectiveness

Return on Assets (ttm)-5.00%
Return on Equity (ttm)-30.59%

Income Statement

Revenue (ttm)11.04M
Revenue Per Share (ttm)0.25
Quarterly Revenue Growth (yoy)-19.00%
Gross Profit (ttm)1.97M
EBITDA -930.16k
Net Income Avi to Common (ttm)-10.7M
Diluted EPS (ttm)-0.2460
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.66M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)8.49M
Total Debt/Equity (mrq)29.32
Current Ratio (mrq)0.86
Book Value Per Share (mrq)0.67

Cash Flow Statement

Operating Cash Flow (ttm)2.06M
Levered Free Cash Flow (ttm)5.56M